echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > One province collection: double envelope improvement, nested 4 + 7 mode landing

    One province collection: double envelope improvement, nested 4 + 7 mode landing

    • Last Update: 2019-08-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the focus in the industry on centralized bidding and purchase of drugs is undoubtedly the nationwide expansion of 4 + 7 combined mining But in addition, with the gradual implementation of the three fixed plans in the reform of government institutions, the centralized procurement of drugs at the provincial level in various regions which has been silent for a long time since 2015 is also gradually on the rise: Guangxi has set a record on the basis of provincial bidding procurement, launched an Autonomous Region Level GPO; Jiangsu has switched the procurement platform, and Jingjiang, Changshu and other places are carrying out small-scale procurement activities But one province, Jiangxi, is preparing for a new round of drug collection The main contents of Jiangxi's volume procurement in 2019 are as follows: 1 Scope of procurement: the top 300 varieties of public medical institutions in the province, and then reduce the varieties that have been evaluated for consistency and are fully competitive at the same time, that is, a small number of large varieties produced by three or more enterprises may be the future volume procurement catalogue Analysis: basically, the scope of procurement is formulated according to the standards of high procurement amount and large quantity, encouraging full competition, and focusing on provincial units Before 2017, this is actually the mainstream practice of drug bidding and purchase in all regions, that is, the provincial level is responsible for the competition and price negotiation of large varieties, and the small varieties are negotiated by local medical consortia or medical institutions But with the development of 4 + 7 in 2018, it has evolved into: provincial price limit formulation, regional volume procurement Therefore, the practice of returning to the provincial level is quite different from that of encouraging prefecture level cities to carry out volume procurement It can be seen that the meaning of provincial "pilot" procurement is still relatively strong 2 Rules for shortlisting: the general direction shall refer to the economic and technical bid score of 15 years, and the comprehensive score shall be given after shortlisting The commercial bid, i.e the price accounts for 40% and the economic technology accounts for 60% It may be one of the lowest prices, one of the highest comprehensive scores and two of the most varieties after being shortlisted (the lowest price is the same and the highest score is the same, ranking will be considered comprehensively) Analysis: according to the current practice of each province, it is often after the evaluation of economic and technical scores that the scores of commercial bids are directly determined, that is, who offers the lowest price, that is, who wins This time, Jiangxi's practice is relatively novel If one of the lowest prices and the one with the highest comprehensive score after comprehensive shortlisting, the advantage of this practice is that it can encourage full price competition, and from another perspective, it is not only to take the low price, avoiding the vicious price killing If the country allows the pilot, will this novel two envelope bidding mode be adopted and implemented by all regions? It is worth pondering 3 Rules of carrying capacity: 50% for the lowest price and 25% for the highest score; 50% for the lowest price and the highest score if they are the same (one bidding period is one year, two bidding periods are two years) Distribution rules: 1 + N, the whole province is still distributed according to 12 medical association points, and only one commercial point can be used to distribute the whole province Analysis: the lowest bid wins 50% of the market, the highest bid wins 25% of the market, and the remaining 25% of the market is for whom? Is there any chance for unsuccessful enterprises to file and supplement their bids? Or is the rest of the market left to the national mining expansion? One bid winning period is one year, and the other two bid winning periods are two years, which is not like the conference spirit set aside by the recent 4 + 7 national expansion? , that is to say, "2 winning varieties for one year, 3 (or more) winning varieties for two to three years" 4 Medical insurance payment: according to the agreed amount, the whole province will be paid by the medical insurance bureau to the supply enterprises (divided into provincial medical insurance and municipal medical insurance) 50% of the agreed amount will be paid in advance, 45% of the agreed amount will be paid after half of the implementation amount or half of the time, and the rest will be paid at last (no separate bidding will be conducted in each city for the time being, and no second price negotiation is allowed) Analysis: at present, health insurance co-ordination is a difficult but also a trend for all provinces Jiangxi province directly participated in this move by provincial and municipal medical insurance, which shows the implementation strength Pay 50% of the agreement amount in advance, and pay 45% of the agreement amount after half of the execution amount or half of the time But the question is, once there is additional purchase, will the payment method be implemented as such? In addition, the advantage of CO payment by provinces and cities is that they will not bid for procurement temporarily This is a good thing for enterprises participating in Jiangxi bidding In Jiangxi pharmaceutical bidding scheme, the bidding method of improved double envelope + not only winning the bid at the lowest price + 4 + 7 nesting + eliminating secondary price negotiation is adopted, which can not only effectively reduce the price, but also consider the problem of drug supply guarantee At the same time, it also provides a reference model for other provinces' pharmaceutical bidding and purchase, which indeed brings a new meaning to the industry Note: the content of this article comes from the disclosure in the industry All policies shall be subject to the official announcement Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.